盈康生命12月29日获融资买入830.47万元，融资余额2.33亿元

Group 1 - The core business of Yingkang Life includes medical devices and medical services, with medical services accounting for 77.47% of revenue and medical devices 22.53% [2] - As of December 19, the number of shareholders of Yingkang Life is 20,100, a decrease of 0.14% from the previous period, with an average of 31,929 circulating shares per person, an increase of 0.14% [2] - For the period from January to September 2025, Yingkang Life achieved operating revenue of 1.358 billion yuan, a year-on-year increase of 10.59%, and a net profit attributable to shareholders of 86.839 million yuan, a year-on-year increase of 5.20% [2] Group 2 - On December 29, Yingkang Life's stock price fell by 1.39%, with a trading volume of 54.3424 million yuan [1] - The financing buy-in amount on December 29 was 8.3047 million yuan, while the financing repayment was 9.973 million yuan, resulting in a net financing buy-in of -1.6683 million yuan [1] - The total balance of margin trading for Yingkang Life as of December 29 is 234 million yuan, with the financing balance accounting for 3.66% of the circulating market value, indicating a high level compared to the past year [1]